BioVinc

BioVinc (BV) has pioneered a groundbreaking skeletal-targeted therapy for life-threatening orthopedic infections and osteomyelitis. This innovation makes it possible to eradicate biofilms, including the previously untreatable MRSA on infected implants—offering new hope to prevent amputation and save lives.